Recurrent and/or metastatic thyroid cancer: therapeutic options.

Recurrent and/or metastatic thyroid cancer: therapeutic options.

Thyroid cancer is relatively rare, accounting for 0.5 - 10 cases per 100,000 individuals per year. Despite their generally favourable prognosis, patients with differentiated thyroid cancer are at risk of tumour recurrence for decades after diagnosis. The optimal management remains controversial even...

Detaylı Bibliyografya
Asıl Yazarlar:	Karavitaki, N, Vlassopoulou, V, Tzanela, M, Tzavara, I, Thalassinos, N
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2002

Benzer Materyaller

Molecular staging using qualitative RT-PCR analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy.
Yazar:: Karavitaki, N, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
Yazar:: Tzanela, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Yazar:: Tzanela, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Novel therapeutic options for recurrent metastatic salivary gland tumors: Review of ongoing clinical trials
Yazar:: Avinash Pandey, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

THERAPEUTIC OPTIONS FOR INVASIVE BREAST CANCER
Yazar:: Ganusevich O. N., ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Metastatic bone disease: Pathogenesis and therapeutic options
Yazar:: Stella D'Oronzo, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
Yazar:: Naimah Turner, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Gliadin encapsulated PCOs nanoformulation: An effective therapeutic option for metastatic breast cancer
Yazar:: Sant Lal, ve diğerleri
Baskı/Yayın Bilgisi: (2025-06-01)

Therapeutic options in older patients with metastatic non-small cell lung cancer
Yazar:: Elisabeth Quoix
Baskı/Yayın Bilgisi: (2012-09-01)

Radiofrequency Ablation of Recurrent Metastatic Papillary Thyroid Cancer to a Lymph Node
Yazar:: Shahzad Ahmad, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Targeted therapeutic options in early and metastatic NSCLC-overview
Yazar:: Gabriella Gálffy, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
Yazar:: Joana S. Reis, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options
Yazar:: Sarah K Premji, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab Vedotin
Yazar:: Jain RK, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Pelvic Exenteration in Advanced, Recurrent or Synchronous Cancers—Last Resort or Therapeutic Option?
Yazar:: Vlad Rotaru, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Therapy options for metastatic triple negative breast cancer
Yazar:: E. V. Glazkova, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Thyroid Cancer Presenting with Concomitant Metastatic Breast Cancer in the Thyroid
Yazar:: Chung-Chen Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2014-12-01)

Metastatic papillary thyroid cancer presenting with a recurrent necrotic cystic cervical lymph node
Yazar:: Alexa Clark, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Current Therapeutic Options in Active Moderate-to-Severe Thyroid-Associated Ophthalmopathy
Yazar:: Stoynova M., ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer
Yazar:: V V Voskoboynikov, ve diğerleri
Baskı/Yayın Bilgisi: (2013-06-01)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
Yazar:: Faiza Naseer, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Choice of treatment options for metastatic hormone-sensitive prostate cancer
Yazar:: R. A. Gafanov, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.
Yazar:: Lixian Zhong, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
Yazar:: Mayara Peres Barbosa, ve diğerleri

Metastatic Thyroid Cancer In A Man With Tumor-Free Thyroid
Yazar:: Spenser S. Souza, MS, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome.
Yazar:: Karavitaki, N, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma.
Yazar:: Alessio Giubellino, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
Yazar:: Paula Colón-Bolea, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

NEW THERAPEUTIC OPTIONS IN THE TREATMENT OF METASTATIC LIMB SARCOMAS: A CASE SERIES
Yazar:: Nicola Ratto
Baskı/Yayın Bilgisi: (2013-04-01)

Occult Metastatic Papillary Thyroid Cancer in an Adolescent
Yazar:: Anna Chin, MD, MPH, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Current management options in metastatic renal cell cancer
Yazar:: Sittu Govindasamy Dinakaran Gangadaran
Baskı/Yayın Bilgisi: (2017-06-01)

Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis
Yazar:: Daniel Sur, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Endometrioid Adenocarcinoma Metastatic to the Thyroid, Presenting Like Anaplastic Thyroid Cancer
Yazar:: Natasha Pollak, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Thyroid crisis caused by metastatic thyroid cancer: an autopsy case report
Yazar:: Kai Takedani, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Metastatic colorectal cancer to a primary thyroid cancer
Yazar:: Swain Sarah, ve diğerleri
Baskı/Yayın Bilgisi: (2008-11-01)

Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells.
Yazar:: Wen Li, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
Yazar:: Nils Degrauwe, ve diğerleri
Baskı/Yayın Bilgisi: (2012-06-01)

Clinical observation of metastatic thyroid disease in a patient with breast cancer
Yazar:: E. V. Bondarenko, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

Selpercatinib – a new option for a precision approach to the treatment of medullary thyroid cancer
Yazar:: A. K. Plugar, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Recurrent follicular thyroid carcinoma metastatic to axillary lymph nodes mimicking pulmonary adenocarcinoma
Yazar:: Stephanie J Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)